{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:57:16Z","timestamp":1792875436653,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13346-024-01787-4","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T15:55:53Z","timestamp":1737042953000},"page":"2904-2923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimizing hydrophilic drug incorporation into SEDDS using dry reverse micelles: a comparative study of preparation methods"],"prefix":"10.1007","volume":"15","author":[{"given":"Sera","family":"Lindner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Sandmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Bohns","family":"Michalowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Di Pretoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-8277","authenticated-orcid":false,"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"4","key":"1787_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrd1067","volume":"2","author":"M Goldberg","year":"2003","unstructured":"Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov. 2003;2(4):289\u201395. https:\/\/doi.org\/10.1038\/nrd1067.","journal-title":"Nat Rev Drug Discov"},{"key":"1787_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/J.ADDR.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/J.ADDR.2016.06.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"1787_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/S41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020;19:277\u201389. https:\/\/doi.org\/10.1038\/S41573-019-0053-0.","journal-title":"Nat Rev Drug Discov"},{"key":"1787_CR4","doi-asserted-by":"publisher","unstructured":"Haddadzadegan S, Dorkoosh F, Bernkop-Schn\u00fcrch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022;182. https:\/\/doi.org\/10.1016\/J.ADDR.2021.114097.","DOI":"10.1016\/J.ADDR.2021.114097"},{"key":"1787_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/J.JCONREL.2014.08.004","volume":"192","author":"I Pereira De Sousa","year":"2014","unstructured":"Pereira De Sousa I, Bernkop-Schn\u00fcrch A. Pre-systemic metabolism of orally administered drugs and strategies to overcome it. J Control Release. 2014;192:301\u20139. https:\/\/doi.org\/10.1016\/J.JCONREL.2014.08.004.","journal-title":"J Control Release"},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","volume":"142","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Bernkop-Schn\u00fcrch A. SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91\u2013101. https:\/\/doi.org\/10.1016\/j.addr.2018.07.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"1787_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijpharm.2017.03.027","volume":"523","author":"G Het\u00e9nyi","year":"2017","unstructured":"Het\u00e9nyi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017;523:357\u201365. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.027.","journal-title":"Int J Pharm"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/J.IJPHARM.2018.01.018","volume":"538","author":"J Griesser","year":"2018","unstructured":"Griesser J, Het\u00e9nyi G, Kadas H, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating. Int J Pharm. 2018;538:159\u201366. https:\/\/doi.org\/10.1016\/J.IJPHARM.2018.01.018.","journal-title":"Int J Pharm"},{"key":"1787_CR9","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1039\/c9na00308h","volume":"1","author":"KD Ristroph","year":"2019","unstructured":"Ristroph KD, Prud\u2019homme RK. Hydrophobic ion pairing: Encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1:4207\u201337. https:\/\/doi.org\/10.1039\/c9na00308h.","journal-title":"Nanoscale Adv"},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpb.2020.09.007","volume":"156","author":"A Gamboa","year":"2020","unstructured":"Gamboa A, Sch\u00fc\u00dfler N, Soto-Bustamante E, Romero-Hasler P, Meinel L, Morales JO. Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids. Eur J Pharm Biopharm. 2020;156:203\u201318. https:\/\/doi.org\/10.1016\/j.ejpb.2020.09.007.","journal-title":"Eur J Pharm Biopharm"},{"key":"1787_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/J.IJPHARM.2017.02.019","volume":"520","author":"J Griesser","year":"2017","unstructured":"Griesser J, Het\u00e9nyi G, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm. 2017;520:267\u201374. https:\/\/doi.org\/10.1016\/J.IJPHARM.2017.02.019.","journal-title":"Int J Pharm"},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40005-021-00549-5","volume":"52","author":"G Noh","year":"2022","unstructured":"Noh G, Keum T, Bashyal S, Seo J-E, Shrawani L, Kim JH, Lee S. Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals. J Pharm Investig. 2022;52:75\u201393. https:\/\/doi.org\/10.1007\/s40005-021-00549-5.","journal-title":"J Pharm Investig"},{"key":"1787_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijpharm.2019.01.039","volume":"559","author":"J Chamieh","year":"2019","unstructured":"Chamieh J, Dom\u00e8nech Tarrat A, Doudou C, Jannin V, Demarne F, Cottet H. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis. Int J Pharm. 2019;559:228\u201334. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.039.","journal-title":"Int J Pharm"},{"key":"1787_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/pr9020345","volume":"9","author":"M-L Arsene","year":"2021","unstructured":"Arsene M-L, R\u0103ut I, C\u0103lin M, Jecu M-L, Doni M, Gurban A-M. Versatility of reverse micelles: From biomimetic models to nano (bio)sensor design. Processes. 2021;9:345. https:\/\/doi.org\/10.3390\/pr9020345.","journal-title":"Processes."},{"key":"1787_CR15","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1021\/cr200254q","volume":"112","author":"NM Correa","year":"2012","unstructured":"Correa NM, Silber JJ, Riter RE, Levinger NE. Nonaqueous polar solvents in reverse micelle systems. Chem Rev. 2012;112:4569\u2013602. https:\/\/doi.org\/10.1021\/cr200254q.","journal-title":"Chem Rev"},{"key":"1787_CR16","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1021\/acs.jpcb.8b07847","volume":"123","author":"R Urano","year":"2019","unstructured":"Urano R, Pantelopulos GA, Straub JE. Aerosol-OT surfactant forms stable reverse micelles in apolar solvent in the absence of water. J Phys Chem B. 2019;123:2546\u201357. https:\/\/doi.org\/10.1021\/acs.jpcb.8b07847.","journal-title":"J Phys Chem B"},{"key":"1787_CR17","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1002\/jps.22205","volume":"99","author":"VJ Stella","year":"2010","unstructured":"Stella VJ. Prodrugs: Some thoughts and current issues. J Pharm Sci. 2010;99:4755\u201365. https:\/\/doi.org\/10.1002\/jps.22205.","journal-title":"J Pharm Sci"},{"key":"1787_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/bit.260400114","volume":"40","author":"SF Matzke","year":"1992","unstructured":"Matzke SF, Creagh AL, Haynes CA, Prausnitz JM, Blanch HW. Mechanisms of protein solubilization in reverse micelles. Biotechnol Bioeng. 1992;40:91\u2013102. https:\/\/doi.org\/10.1002\/bit.260400114.","journal-title":"Biotechnol Bioeng"},{"key":"1787_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ejpb.2011.02.015","volume":"79","author":"S Vrignaud","year":"2011","unstructured":"Vrignaud S, Anton N, Gayet P, Benoit J-P, Saulnier P. Reverse micelle-loaded lipid nanocarriers: A novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur J Pharm Biopharm. 2011;79:197\u2013204. https:\/\/doi.org\/10.1016\/j.ejpb.2011.02.015.","journal-title":"Eur J Pharm Biopharm"},{"key":"1787_CR20","doi-asserted-by":"publisher","first-page":"2302034","DOI":"10.1002\/adhm.202302034","volume":"12","author":"AM J\u00f6rgensen","year":"2023","unstructured":"J\u00f6rgensen AM, Steinbring C, Stengel D, To D, Schmid P, Bernkop-Schn\u00fcrch A. Self-emulsifying drug delivery systems (SEDDS) containing reverse micelles: advanced oral formulations for therapeutic peptides. Adv Healthc Mater. 2023;12:2302034. https:\/\/doi.org\/10.1002\/adhm.202302034.","journal-title":"Adv Healthc Mater."},{"key":"1787_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijpharm.2012.06.026","volume":"436","author":"S Vrignaud","year":"2012","unstructured":"Vrignaud S, Hureaux J, Wack S, Benoit J-P, Saulnier P. Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm. 2012;436:194\u2013200. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.06.026.","journal-title":"Int J Pharm"},{"key":"1787_CR22","doi-asserted-by":"publisher","first-page":"9768","DOI":"10.1007\/s12274-023-5645-7","volume":"16","author":"M Lin","year":"2023","unstructured":"Lin M, Wu L, Lu Y, Bao X, Zhong H, Dai Q, Yang Q, Xia Y, Tan X, Qin Y, Jiang R, Han M. Membrane fusion reverse micelle platforms as potential oral nanocarriers for efficient internalization of free hydrophilic peptides. Nano Res. 2023;16:9768\u201380. https:\/\/doi.org\/10.1007\/s12274-023-5645-7.","journal-title":"Nano Res"},{"key":"1787_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/47.1.1","volume":"47","author":"M Wainwright","year":"2001","unstructured":"Wainwright M. Acridine\u2014a neglected antibacterial chromophore. J Antimicrob Chemother. 2001;47:1\u201313. https:\/\/doi.org\/10.1093\/jac\/47.1.1.","journal-title":"J Antimicrob Chemother"},{"key":"1787_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3103\/S0027134920060211","volume":"75","author":"OI Volkova","year":"2020","unstructured":"Volkova OI, Kuleshova AA, Saletsky AM. The effect of nanoscale reverse micelles on the photophysical properties of fluorescein molecules. Mosc Univ Phys Bull. 2020;75:605\u201310. https:\/\/doi.org\/10.3103\/S0027134920060211.","journal-title":"Mosc Univ Phys Bull"},{"key":"1787_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1046\/j.1365-2958.2003.03786.x","volume":"50","author":"T Mascher","year":"2003","unstructured":"Mascher T, Margulis NG, Wang T, Ye RW, Helmann JD. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon. Mol Microbiol. 2003;50:1591\u2013604. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03786.x.","journal-title":"Mol Microbiol"},{"key":"1787_CR26","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1021\/acs.molpharmaceut.0c00343","volume":"17","author":"AM J\u00f6rgensen","year":"2020","unstructured":"J\u00f6rgensen AM, Friedl JD, Wibel R, Chamieh J, Cottet H, Bernkop-Schn\u00fcrch A. Cosolvents in Self-Emulsifying Drug Delivery Systems (SEDDS): Do they really solve our solubility problems? Mol Pharm. 2020;17:3236\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00343.","journal-title":"Mol Pharm"},{"key":"1787_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01538-5","author":"K Z\u00f6ller","year":"2024","unstructured":"Z\u00f6ller K, Haddadzadegan S, Lindner S, Veider F, Bernkop-Schn\u00fcrch A. Design of charge converting lipid nanoparticles via a microfluidic coating technique. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01538-5.","journal-title":"Drug Deliv Transl Res"},{"key":"1787_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jcis.2023.10.001","volume":"654","author":"K Z\u00f6ller","year":"2024","unstructured":"Z\u00f6ller K, Karlegger A, Truszkowska M, Stengel D, Bernkop-Schn\u00fcrch A. Fluorescent hydrophobic ion pairs: A powerful tool to investigate cellular uptake of hydrophobic drug complexes via lipid-based nanocarriers. J Colloid Interface Sci. 2024;654:174\u201388. https:\/\/doi.org\/10.1016\/j.jcis.2023.10.001.","journal-title":"J Colloid Interface Sci"},{"key":"1787_CR29","doi-asserted-by":"publisher","first-page":"2181744","DOI":"10.1080\/10717544.2023.2181744","volume":"30","author":"J He","year":"2023","unstructured":"He J, Ding R, Tao Y, Zhao Z, Yuan R, Zhang H, Wang A, Sun K, Li Y, Shi Y. Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides. Drug Deliv. 2023;30:2181744. https:\/\/doi.org\/10.1080\/10717544.2023.2181744.","journal-title":"Drug Deliv"},{"key":"1787_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/GUTJNL-2019-319146","volume":"69","author":"Y Xu","year":"2020","unstructured":"Xu Y, Van Hul M, Suriano F, Pr\u00e9at V, Cani PD, Beloqui A. Novel strategy for oral peptide delivery in incretin-based diabetes treatment. Gut. 2020;69:911\u20139. https:\/\/doi.org\/10.1136\/GUTJNL-2019-319146.","journal-title":"Gut"},{"key":"1787_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejpb.2023.09.003","volume":"191","author":"Y Lu","year":"2023","unstructured":"Lu Y, Wu L, Lin M, Bao X, Zhong H, Ke P, Dai Q, Yang Q, Tang X, Xu W, Xu D, Han M. Double layer spherical nanoparticles with hyaluronic acid coating to enhance oral delivery of exenatide in T2DM rats. Eur J Pharm Biopharm. 2023;191:205\u201318. https:\/\/doi.org\/10.1016\/j.ejpb.2023.09.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"1787_CR32","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1021\/la9709047","volume":"14","author":"CAT Laia","year":"1998","unstructured":"Laia CAT, L\u00f3pez-Cornejo P, Costa SMB, d\u2019Oliveira J, Martinho JMG. Dynamic light scattering study of AOT microemulsions with nonaqueous polar additives in an oil continuous phase. Langmuir. 1998;14:3531\u20137. https:\/\/doi.org\/10.1021\/la9709047.","journal-title":"Langmuir"},{"key":"1787_CR33","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1039\/B917197E","volume":"11","author":"RD Falcone","year":"2009","unstructured":"Falcone RD, Silber JJ, Correa NM. What are the factors that control non-aqueous\/AOT\/n-heptane reverse micelle sizes? A dynamic light scattering study. Phys Chem Chem Phys. 2009;11:11096\u2013100. https:\/\/doi.org\/10.1039\/B917197E.","journal-title":"Phys Chem Chem Phys"},{"key":"1787_CR34","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1080\/01932691.2019.1656084","volume":"41","author":"M Ma","year":"2020","unstructured":"Ma M, Song J, Bai L, Wei G, Dai J, Chen Z, Yin T. Effect of H-bonding effect on reverse micelle extraction of bovine serum albumin. J Dispers Sci Technol. 2020;41:2169\u201375. https:\/\/doi.org\/10.1080\/01932691.2019.1656084.","journal-title":"J Dispers Sci Technol"},{"key":"1787_CR35","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.1063\/1.1738641","volume":"120","author":"J Pi\u00f1ero","year":"2004","unstructured":"Pi\u00f1ero J, Bhuiyan LB, Bratko D. Electrostatic interactions of charged dipolar proteins in reverse micelles. J Chem Phys. 2004;120:11941\u20137. https:\/\/doi.org\/10.1063\/1.1738641.","journal-title":"J Chem Phys"},{"key":"1787_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.11308\/tjsst.15.36","volume":"15","author":"Y Ono","year":"2023","unstructured":"Ono Y, Mizuguchi T, Fukuyama M. Analysis of Hydrogen Bonds inside Span 80 Reverse Micelles by Molecular Dynamics Simulations. Trans Japan Soc Simul Technol. 2023;15:36\u201341. https:\/\/doi.org\/10.11308\/tjsst.15.36.","journal-title":"Trans Japan Soc Simul Technol"},{"key":"1787_CR37","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1021\/la904033e","volume":"26","author":"J-L Lemyre","year":"2010","unstructured":"Lemyre J-L, Ritcey AM. Characterization of a reverse micellar system by 1H NMR. Langmuir. 2010;26:6250\u20135. https:\/\/doi.org\/10.1021\/la904033e.","journal-title":"Langmuir"},{"key":"1787_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-anchem-070109-103410","volume":"3","author":"MD Fayer","year":"2010","unstructured":"Fayer MD, Levinger NE. Analysis of water in confined geometries and at interfaces. Annu Rev Anal Chem. 2010;3:89\u2013107. https:\/\/doi.org\/10.1146\/annurev-anchem-070109-103410.","journal-title":"Annu Rev Anal Chem"},{"key":"1787_CR39","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1039\/C1SM05204G","volume":"7","author":"TL Spehr","year":"2011","unstructured":"Spehr TL, Frick B, Zamponi M, St\u00fchn B. Dynamics of water confined to reverse AOT micelles. Soft Matter. 2011;7:5745\u201355. https:\/\/doi.org\/10.1039\/C1SM05204G.","journal-title":"Soft Matter"},{"key":"1787_CR40","doi-asserted-by":"publisher","first-page":"21767","DOI":"10.1039\/C6CP04378J","volume":"18","author":"VR Hande","year":"2016","unstructured":"Hande VR, Chakrabarty S. Exploration of the presence of bulk-like water in AOT reverse micelles and water-in-oil nanodroplets: the role of charged interfaces, confinement size and properties of water. Phys Chem Chem Phys. 2016;18:21767\u201379. https:\/\/doi.org\/10.1039\/C6CP04378J.","journal-title":"Phys Chem Chem Phys"},{"key":"1787_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.JCONREL.2017.12.027","volume":"271","author":"A Bernkop-Schn\u00fcrch","year":"2018","unstructured":"Bernkop-Schn\u00fcrch A, Jalil A. Do drug release studies from SEDDS make any sense? J Control Release. 2018;271:55\u20139. https:\/\/doi.org\/10.1016\/J.JCONREL.2017.12.027.","journal-title":"J Control Release"},{"key":"1787_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03639045.2012.660949","volume":"39","author":"MA Rahman","year":"2013","unstructured":"Rahman MA, Hussain A, Hussain MS, Mirza MA, Iqbal Z. Role of excipients in successful development of self-emulsifying\/ microemulsifying drug delivery system (SEDDS\/SMEDDS). Drug Dev Ind Pharm. 2013;39:1\u201319. https:\/\/doi.org\/10.3109\/03639045.2012.660949.","journal-title":"Drug Dev Ind Pharm"},{"key":"1787_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.ADDR.2018.10.014","volume":"142","author":"I Nardin","year":"2019","unstructured":"Nardin I, K\u00f6llner S. Successful development of oral SEDDS: screening of excipients from the industrial point of view. Adv Drug Deliv Rev. 2019;142:128\u201340. https:\/\/doi.org\/10.1016\/J.ADDR.2018.10.014.","journal-title":"Adv Drug Deliv Rev"},{"key":"1787_CR44","doi-asserted-by":"publisher","first-page":"124267","DOI":"10.1016\/j.ijpharm.2024.124267","volume":"659","author":"G Balenzano","year":"2024","unstructured":"Balenzano G, Racaniello GF, Spennacchio A, Lopalco A, Iacobazzi RM, Lopedota AA, Laquintana V, Denora N. Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery. Int J Pharm. 2024;659:124267. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124267.","journal-title":"Int J Pharm"},{"key":"1787_CR45","doi-asserted-by":"publisher","unstructured":"van Meerloo J, Kaspers GJL, Cloos J. Cell sensitivity assays: the MTT assay. In: Cree IA, ed Cancer Cell Culture: Methods and Protocols, Humana Press, Totowa, NJ, 2011. pp. 237\u2013245. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_20.","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"1787_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/jfb5020043","volume":"5","author":"J L\u00f3pez-Garc\u00eda","year":"2014","unstructured":"L\u00f3pez-Garc\u00eda J, Lehock\u00fd M, Humpol\u00ed\u010dek P, S\u00e1ha P. HaCaT keratinocytes response on antimicrobial atelocollagen substrates: extent of cytotoxicity, cell viability and proliferation. J Funct Biomater. 2014;5:43\u201357. https:\/\/doi.org\/10.3390\/jfb5020043.","journal-title":"J Funct Biomater"},{"key":"1787_CR47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1079\/BJN20041094","volume":"91","author":"SM O\u2019Sullivan","year":"2004","unstructured":"O\u2019Sullivan SM, Woods JA, O\u2019Brien NM. Use of Tween 40 and Tween 80 to deliver a mixture of phytochemicals to human colonic adenocarcinoma cell (CaCo-2) monolayers. Br J Nutr. 2004;91:757\u201364. https:\/\/doi.org\/10.1079\/BJN20041094.","journal-title":"Br J Nutr"},{"key":"1787_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/scipharm85020018","volume":"85","author":"H Rachmawati","year":"2017","unstructured":"Rachmawati H, Novel MA, Ayu S, Berlian G, Tandrasasmita OM, Tjandrawinata RR, Anggadiredja K. The in vitro\u2013in vivo safety confirmation of PEG-40 hydrogenated castor oil as a surfactant for oral nanoemulsion formulation. Sci Pharm. 2017;85:18. https:\/\/doi.org\/10.3390\/scipharm85020018.","journal-title":"Sci Pharm."},{"key":"1787_CR49","doi-asserted-by":"publisher","first-page":"e07433","DOI":"10.2903\/j.efsa.2022.7433","volume":"20","author":"V Bampidis","year":"2022","unstructured":"Bampidis V, Azimonti G, de L Bastos M, Christensen H, Dusemund B, Fa\u0161mon Durjava M, Kouba M, L\u00f3pez-Alonso M, L\u00f3pez Puente S, Marcon F, Mayo B, Pechov\u00e1 A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Aquilina G, Bories G, Gropp J, Nebbia C, Innocenti M. Safety and efficacy of a feed additive consisting of glyceryl polyethyleneglycol ricinoleate (PEG castor oil) for all animal species (FEFANA asbl). EFSA J. 2022;20:7433. https:\/\/doi.org\/10.2903\/j.efsa.2022.7433.","journal-title":"EFSA J"},{"key":"1787_CR50","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1248\/bpb.25.605","volume":"25","author":"T Uchino","year":"2002","unstructured":"Uchino T, Tokunaga H, Onodera H, Ando M. Effect of squalene monohydroperoxide on cytotoxicity and cytokine release in a three-dimensional human skin model and human epidermal keratinocytes. Biol Pharm Bull. 2002;25:605\u201310. https:\/\/doi.org\/10.1248\/bpb.25.605.","journal-title":"Biol Pharm Bull"},{"key":"1787_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.20772\/cancersci1985.76.4_315","volume":"76","author":"M Nakagawa","year":"1985","unstructured":"Nakagawa M, Yamaguchi T, Fukawa H, Ogata J, Komiyama S, Akiyama S, Kuwano M. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. Jpn J Cancer Res. 1985;76:315\u201320. https:\/\/doi.org\/10.20772\/cancersci1985.76.4_315.","journal-title":"Jpn J Cancer Res"},{"key":"1787_CR52","doi-asserted-by":"publisher","first-page":"e21461","DOI":"10.1016\/j.heliyon.2023.e21461","volume":"9","author":"MP Bhat","year":"2023","unstructured":"Bhat MP, Rudrappa M, Hugar A, Gunagambhire PV, Suresh Kumar R, Nayaka S, Almansour AI, Perumal K. In-vitro investigation on the biological activities of squalene derived from the soil fungus Talaromyces pinophilus. Heliyon. 2023;9:e21461. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21461.","journal-title":"Heliyon"},{"key":"1787_CR53","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.apsb.2020.02.001","volume":"10","author":"T Wang","year":"2020","unstructured":"Wang T, Guo Y, He Y, Ren T, Yin L, Fawcett JP, Gu J, Sun H. Impact of molecular weight on the mechanism of cellular uptake of polyethylene glycols (PEGs) with particular reference to P-glycoprotein. Acta Pharm Sin B. 2020;10:2002\u20139. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.001.","journal-title":"Acta Pharm Sin B"},{"key":"1787_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1248\/bpb.b23-00570","volume":"47","author":"T Takiguchi","year":"2024","unstructured":"Takiguchi T, Sugio K, Masuda M, Sasaki S, Miyauchi S. Uptake of fluorescein via a pH-dependent monocarboxylate transporter by Human Kidney 2 (HK-2) cells. Biol Pharm Bull. 2024;47:79\u201387. https:\/\/doi.org\/10.1248\/bpb.b23-00570.","journal-title":"Biol Pharm Bull"},{"key":"1787_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-2952(01)00853-X","volume":"63","author":"K Kuwayama","year":"2002","unstructured":"Kuwayama K, Miyauchi S, Tateoka R, Abe H, Kamo N. Fluorescein uptake by a monocarboxylic acid transporter in human intestinal Caco-2 cells. Biochem Pharmacol. 2002;63:81\u20138. https:\/\/doi.org\/10.1016\/S0006-2952(01)00853-X.","journal-title":"Biochem Pharmacol"},{"key":"1787_CR56","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1021\/mp500439c","volume":"11","author":"AM Bannunah","year":"2014","unstructured":"Bannunah AM, Vllasaliu D, Lord J, Stolnik S. Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge. Mol Pharm. 2014;11:4363\u201373. https:\/\/doi.org\/10.1021\/mp500439c.","journal-title":"Mol Pharm"},{"key":"1787_CR57","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1039\/C8SC01828F","volume":"9","author":"D Zhang","year":"2018","unstructured":"Zhang D, Wei L, Zhong M, Xiao L, Li H-W, Wang J. The morphology and surface charge-dependent cellular uptake efficiency of upconversion nanostructures revealed by single-particle optical microscopy. Chem Sci. 2018;9:5260\u20139. https:\/\/doi.org\/10.1039\/C8SC01828F.","journal-title":"Chem Sci"},{"key":"1787_CR58","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012;7:5577\u201391. https:\/\/doi.org\/10.2147\/IJN.S36111.","journal-title":"Int J Nanomedicine"},{"key":"1787_CR59","doi-asserted-by":"publisher","unstructured":"Friedl JD, J\u00f6rgensen AM, Le Nguyen NM, Steinbring C, Bernkop-Schn\u00fcrch A. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery. Int J Pharm. 2022;618. https:\/\/doi.org\/10.1016\/J.IJPHARM.2022.121633.","DOI":"10.1016\/J.IJPHARM.2022.121633"},{"key":"1787_CR60","doi-asserted-by":"publisher","unstructured":"Friedl JD, Steinbring C, Zaichik S, Le N-MN, Bernkop-Schn\u00fcrch A. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface. Nanomedicine. 2020;15:1829\u20131841. https:\/\/doi.org\/10.2217\/NNM-2020-0127.","DOI":"10.2217\/NNM-2020-0127"},{"key":"1787_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcis.2023.05.079","volume":"647","author":"D Stengel","year":"2023","unstructured":"Stengel D, Demirel BH, Knoll P, Truszkowska M, Laffleur F, Bernkop-Schn\u00fcrch A. PEG vs. zwitterions: How these surface decorations determine cellular uptake of lipid-based nanocarriers. J Colloid Interface Sci. 2023;647:52\u201364. https:\/\/doi.org\/10.1016\/j.jcis.2023.05.079.","journal-title":"J Colloid Interface Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01787-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01787-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01787-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:44:53Z","timestamp":1751388293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01787-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01787-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"27 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Andreas Bernkop-Schn\u00fcrch reports financial support was provided by Johnson & Johnson Innovative Medicine. Dajun Sun, Nathaniel Washburn, Cecilia Bohns Michalowski and Giustino Di Pretoro report a relationship with Johnson & Johnson Innovative Medicine that includes: employment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}